Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 16 | 0 | 2 | 0 | €97.12 | €116.81 | 20.272% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.46 | €174.43 | 16.709% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €3.90 | €34.41 | 782.374% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.25 | €10.00 | 21.286% |
| Adverum Biotechnologies Inc. | 6 | 0 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| Akebia Therapeutics Inc. | 8 | 2 | 1 | 0 | €1.19 | €3.64 | 205.738% |
| Akero Therapeutics Inc | 13 | 0 | 1 | 0 | €19.44 | €38.62 | 98.679% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.44 | - | - |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €139.00 | €236.30 | 69.999% |
| Amgen Inc. | 25 | 0 | 5 | 0 | €285.95 | €297.31 | 3.973% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.20 | €10.00 | 61.290% |
| AnaptysBio Inc | 9 | 1 | 4 | 0 | €22.00 | €45.21 | 105.500% |
| Anika Therapeutics | 5 | 0 | 1 | 0 | €23.60 | €28.29 | 19.876% |
| Apellis Pharmaceuticals | 3 | 0 | 0 | 0 | €39.86 | €70.00 | 75.615% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €7.44 | €11.00 | 47.889% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €8.15 | €8.75 | 7.362% |
| Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €70.14 | €100.00 | 42.572% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €5.22 | €11.05 | 111.470% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €208.90 | €294.01 | 40.742% |
| Biolife Solutions Inc | 2 | 0 | 2 | 0 | €18.90 | €32.00 | 69.312% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.16 | €102.62 | 34.741% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €100.15 | - | - |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.50 | - | - |